TCRT ALAUNOS THERAPEUTICS INC Capital Structure Changes 8-K Filing 2023 - Annual Meeting Approval Alaunos Therapeutics, Inc. held its Annual Meeting and approved an amendment to increase the number of authorized shares of common stock from 420,000,000 to 520,000,000.Get access to all SEC 8-K filings of the ALAUNOS THERAPEUTICS INC